StockWatch
·

TENET HEALTHCARE CORP Q3 FY26 Results

THCQ3 FY26 Results
Filing
MetricValue ($ M)Q2 FY26Q3 FY25
Revenue5.6K0.1%6.5%
Total Income5.6K0.1%6.5%
Expenditure3.9K6.0%11.8%
PBT—
Net Profit1.0K21.1%192.4%
OPM31.08%4.41pp14.27pp
NPM17.76%3.08pp11.29pp
EPS12.4826.2%220.8%
View full financials

Tenet Healthcare Reports Strong Q3 2026 Results; Raises 2026 Financial Outlook

29 Oct 2026 · 29 Oct, 4:21 pm

Summary

Tenet Healthcare Corporation reported strong third quarter 2026 results, with net income available to common shareholders reaching $1.000 billion, or $12.41 per diluted share, up from $342 million in the prior year. Consolidated Adjusted EBITDA increased by 23.3% to $1.355 billion, and the company raised its full-year 2026 Adjusted EBITDA outlook to a range of $5.05 billion to $5.20 billion. Management attributed the outperformance to sustained strength in same-store revenue growth and effective expense management.

Key Highlights

  1. 1

    Net income available to common shareholders in the third quarter of 2026 was $1.000 billion, or $12.41 per diluted share, a significant increase from $342 million, or $3.86 per diluted share, in the third quarter of 2025.

  2. 2

    Adjusted diluted earnings per share increased by 79.5% to $6.64 in the third quarter of 2026 compared to $3.70 in the third quarter of 2025.

  3. 3

    Consolidated Adjusted EBITDA for the third quarter of 2026 rose by 23.3% over the third quarter of 2025 to $1.355 billion, with an Adjusted EBITDA margin of 24.1%.

  4. 4

    The Ambulatory Care segment's Adjusted EBITDA reached $537 million in the third quarter of 2026, an increase of 9.1% over the third quarter of 2025.

  5. 5

    The FY 2026 Adjusted EBITDA outlook was raised to a range of $5.05 billion to $5.20 billion, an increase of $195 million at the midpoint.

  6. 6

    Net operating revenues for the third quarter of 2026 were $5.631 billion, an increase of 6.5% compared to $5.289 billion in the third quarter of 2025.

Management Comments

S

Saum Sutaria

M.D.

Our outperformance in the third quarter of 2026 was driven by sustained strength in same-store revenue growth and effective expense management. Our focus on patient-centered care, support for physician partners, technology-enabled growth and operating initiatives continue to deliver strong margins and free cash flow.

Informational and educational content only. Not investment advice.